What are the differences and key steps in Analytical Method Development, Qualification, and Validation

The process for pharmaceutical analytical method development, qualification, and validation involves several crucial steps and is very different. Method development focuses on creating a reliable method, qualification evaluates its performance, and validation ensures it meets regulatory criteria for the intended use. These steps collectively ensure accurate and consistent analytical results in pharmaceutical research and quality control.

The objective of Analytical Method Development is to create a robust and reliable analytical method for quantifying specific substances (e.g., drug compounds) in pharmaceutical samples. There are several steps in the process. First, clearly define the purpose and objectives of the method. Second, conduct a literature review to investigate existing methods and scientific literature. Next, create a detailed plan for the method. Then fine-tune parameters (e.g., sample preparation, reagents, conditions). Finally, assess the method's performance and robustness under varying conditions. In a experienced system, knowledge management-driven, platform-based analytical method development approach can be conducted efficiently with standardized development plan.

The purpose of Analytical Method Qualification is to evaluate and characterize the performance of the method as an analytical tool in the early stage. You need to focus on several key factors:

Similar to Qualification, Analytical Method Validation aims to demonstrate that the method’s performance meets its intended use for late, post-approval stages in advance. All the acceptance criteria should be defined before executing method validation. This is done by testing various validation parameters such as:

  -  Specificity: Confirm analyte selectivity.
  -  Robustness: Evaluate performance under variable conditions.
  -  Precision: Assess repeatability and intermediate precision or reproducibility (across sites).
  -  Accuracy: Verify closeness to true values.
  -  Linearity: Validate the linear relationship.
  -  Range: Define the valid concentration range.
  -  LOD and LOQ: Establish detection and quantitation limits.
  -  Stability: Assess the method's long-term stability over time.

Next, let’s look at the key steps involved in each of these. Remember that these steps are critical for ensuring the accuracy, reliability, and reproducibility of analytical methods used in pharmaceutical quality control and research.

2.  Analytical Procedures Content:

  a)  Clearly state the principle and scope of the analytical procedure.
  b)  Specify the instruments, equipment, and materials required.
  c)  Define the operating parameters/conditions (e.g., temperature, flow rate, wavelength).
  d)  List the reagents, solvents, and standards needed.
  e)  Describe the sample preparation steps.
  f)  Detail the preparation of standard solutions.
  g)  Provide step-by-step instructions for the analysis.
  h)  Include criteria for system suitability testing.

3.  Method Qualification (Validation):

4.  Continued Method Performance Verification:

  a)  Regularly monitor the method’s performance during routine use.
  b)  Conduct system suitability tests to ensure consistent results.
  c)  Implement appropriate change control procedures when modifying the method.
  d)  If transferring the method to another laboratory, ensure its successful adaptation.

Remember that these steps are critical for ensuring the accuracy, reliability, and reproducibility of analytical methods used in pharmaceutical quality control and research.

Lastly, let’s explore the regulatory guidelines for pharmaceutical method validation:

1.  FDA Guidance for Industry - Analytical Procedures and Methods Validation for Drugs and Biologics:

2.  ICH Q14 - Validation of Analytical Procedures:

  a)  Developed by the International Council for Harmonization (ICH).
  b)  Provides guidance on science and risk-based approaches for developing and maintaining analytical procedures suitable for the evaluation of the quality of drug substances and drug products.
   c)  Intended to facilitate regulatory evaluations and potential flexibility in the post approval change of analytical procedure lifecycle management.

d)  https://www.fda.gov/media/161202/download

3.  ICH Q2(R2) - Validation of Analytical Procedures:

4.  FDA Guidance for Industry - Process Validation: General Principles and Practices:

In summary, these guidelines ensure that analytical methods used in pharmaceutical research and quality control meet rigorous standards for accuracy, reliability, and consistency.

 References:

• Analytical Procedures and Methods Validation for Drugs and Biologics- https://www.fda.gov/files/drugs/published/Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf
• A Step-by-Step Guide to Analytical Method Development and Validation - https://emerypharma.com/blog/a-step-by-step-guide-to-analytical-method-development-and-validation/
  Analytical Method Lifecycle Management in Pharmaceutical Industry: a Review - https://link.springer.com/article/10.1208/s12249-021-01960-9
• Lifecycle Management of Analytical Procedures: Method Development, Procedure Performance Qualification, and Procedure Performance Verification - https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/revisions/lifecycle_pdf.pdf
• FDA Guidance | Drugs - https://www.fda.gov/drugs/guidance-compliance-regulatory-information/guidances-drugs
  
• FDA Biologics Guidance - https://www.fda.gov/vaccines-blood-biologics/guidance-compliance-regulatory-information-biologics/biologics-guidances
• Method Development, Qualification, and Validation - https://www.altasciences.com/analytical-laboratory-services/method-development-qualification-and-validation
  
  

Consider working with EirGenix!

Are you seeking a contract development and manufacturing partner that has it all – quality, reliability, flexibility, and reasonable pricing? At EirGenix, we offer all of this and top-notch customer service. Since 2012, EirGenix has offered mammalian and microbial biopharma development and production including cell line establishment, large-scale production process development, analytical method development, and cGMP quality system operations that are certified by the US FDA, Japan PMDA, Australian TGA, Taiwan FDA, and Europe EMA. We would appreciate the opportunity to collaborate with you!

You can virtually tour our site here. We would appreciate the opportunity to collaborate with you! Click on this link to contact our BD team.